{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:47:50Z","timestamp":1782366470257,"version":"3.54.5"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genome Ed."],"abstract":"<jats:p>\n                    Influenza A virus (IAV) and influenza B virus (IBV) remain major global public health threats because of their rapid antigenic evolution and efficient human-to-human transmission. In contrast, influenza C virus (ICV) and influenza D virus (IDV) generally exhibit narrower host ranges and milder pathogenicity, yet their potential for interspecies transmission and zoonotic spillover still warrants attention. Conventional prevention strategies, such as inactivated and live-attenuated vaccines, suffer from prolonged development timelines and diminished efficacy against rapidly evolving viral strains. However, antiviral drugs are increasingly limited by the rapid emergence of drug-resistant variants. The clustered regularly interspaced short palindromic repeats (CRISPR)\/CRISPR-associated (Cas) gene-editing technology has emerged as a promising platform for influenza prevention and control owing to its programmability and precise targeting capability. In this paper, we summarize recent advances in CRISPR-based strategies for influenza prevention and control. The RNA-targeting CRISPR-associated protein 13 (Cas13) system can recognize conserved viral RNA sequences and suppress replication across influenza subtypes, whereas the DNA-targeting CRISPR-associated protein 9 (Cas9) system can edit host susceptibility genes and thereby reduce cellular permissiveness to infection. In addition, lipid nanoparticle (LNP)-based delivery systems have become important tools for improving the\n                    <jats:italic>in vivo<\/jats:italic>\n                    delivery and expression of CRISPR components by enhancing targeting efficiency and reducing immunogenicity. CRISPR-based diagnostics, such as Specific High-sensitivity Enzymatic Reporter unLOCKing (SHERLOCK), further expand the clinical utility of this technology by enabling rapid and sensitive detection of influenza viruses. Despite these advances, substantial challenges remain, including delivery inefficiency, off-target activity, long-term safety concerns, and the risk of viral escape. With continued technological refinement and careful translational development, CRISPR may become a versatile tool for influenza prevention, diagnosis, and therapy.\n                  <\/jats:p>","DOI":"10.3389\/fgeed.2026.1844919","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:30:34Z","timestamp":1782365434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The application of CRISPR gene-editing technology in influenza prevention and control"],"prefix":"10.3389","volume":"8","author":[{"given":"Xinyi","family":"Zhang","sequence":"first","affiliation":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangyi","family":"Shi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Yang","sequence":"additional","affiliation":[{"name":"Gongshu District People\u2019s Hospital of Integrated Traditional Chinese and Western Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lailing","family":"Du","sequence":"additional","affiliation":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"745559","DOI":"10.3389\/fgeed.2021.745559","article-title":"The application of CRISPR\/Cas systems for antiviral therapy","volume":"3","author":"Baddeley","year":"2021","journal-title":"Front. GENOME Ed."},{"key":"B3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/ijms25010334","article-title":"CRISPR\/Cas9 as a new antiviral strategy for treating hepatitis viral infections","volume":"25","author":"Bartosh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00018-022-04175-8","article-title":"Maybe you can turn me on: crispra-based strategies for therapeutic applications","volume":"79","author":"Becirovic","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ymthe.2024.11.024","article-title":"Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems","volume":"33","author":"Broks\u00f8","year":"2025","journal-title":"Mol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1021\/acs.analchem.1c04795","article-title":"Physicochemical and functional characterization of differential CRISPR-Cas9 ribonucleoprotein complexes","volume":"94","author":"Camperi","year":"2022","journal-title":"Anal. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/17425247.2023.2185220","article-title":"Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases","volume":"20","author":"Carneiro","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"B8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/01926233231202995","article-title":"Safety findings of dosing gene therapy vectors in NHP with pre-existing or treatment-emergent anti-capsid antibodies","volume":"51","author":"Chandra","year":"2023","journal-title":"Toxicol. Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1038\/s41598-021-87845-0","article-title":"Potent sialic acid inhibitors that target influenza A virus hemagglutinin","volume":"11","author":"Chang","year":"2021","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.omtm.2022.10.016","article-title":"Population-wide gene disruption in the murine lung epithelium via AAV-mediated delivery of CRISPR-Cas9 components","volume":"27","author":"Chen","year":"2022","journal-title":"Mol. Ther. METHODS and Clin. Dev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"146665","DOI":"10.1016\/j.ijbiomac.2025.146665","article-title":"IAV inhibits the host antiviral defense mediated by LncRNA-LRIR to enhance viral replication","volume":"322","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1408","DOI":"10.1002\/wsbm.1408","article-title":"Immunity to CRISPR Cas9 and Cas12a therapeutics","volume":"10","author":"Chew","year":"2018","journal-title":"WILEY Interdiscip. Reviews-Systems Biol. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1399993","DOI":"10.3389\/fviro.2024.1399993","article-title":"An overview of SARS-CoV-2 viral proteins with relevance to improved diagnostic and therapeutic platforms","volume":"4","author":"Chung","year":"2024","journal-title":"Front. VIROLOGY"},{"key":"B14","first-page":"170","article-title":"CRISPR advancements for human health","volume":"121","author":"Davis","year":"2024","journal-title":"Mo Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/biom15010075","article-title":"TMPRSS2 as a key player in viral pathogenesis: influenza and coronaviruses","volume":"15","author":"de Lima","year":"2025","journal-title":"Biomolecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100854","DOI":"10.1016\/j.ajps.2023.100854","article-title":"CRISPR\/Cas9 systems: delivery technologies and biomedical applications","volume":"18","author":"Du","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1038\/s41467-021-24577-9","article-title":"Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance","volume":"12","author":"Fareh","year":"2021","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1021\/acsnano.4c16617","article-title":"Lipid nanoparticles for in vivo lung delivery of CRISPR-Cas9 ribonucleoproteins allow gene editing of clinical targets","volume":"19","author":"Haley","year":"2025","journal-title":"ACS Nano"},{"key":"B20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.celrep.2018.03.045","article-title":"Genome-wide CRISPR\/Cas9 screen identifies host factors essential for influenza virus replication","volume":"23","author":"Han","year":"2018","journal-title":"Cell. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1039\/d5bm00322a","article-title":"Non-viral mRNA delivery to the lungs","volume":"13","author":"Healy","year":"2025","journal-title":"Biomater. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.chom.2021.09.001","article-title":"Viral recombination systems limit CRISPR-Cas targeting through the generation of escape mutations","volume":"29","author":"Hossain","year":"2021","journal-title":"Cell. Host Microbe"},{"key":"B23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.actbio.2024.03.031","article-title":"Immunometabolic reprogramming of macrophages with inhalable CRISPR\/Cas9 nanotherapeutics for acute lung injury intervention","volume":"181","author":"Huang","year":"2024","journal-title":"Acta Biomater."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00580-17","DOI":"10.1128\/JB.00580-17","article-title":"History of CRISPR-Cas from encounter with a mysterious repeated sequence to genome editing technology","volume":"200","author":"Ishino","year":"2018","journal-title":"J. Bacteriol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000547334","article-title":"Challenges and opportunities in the application of CRISPR-Cas9: a review on genomic editing and therapeutic potentials","volume":"35","author":"Karimi","year":"2026","journal-title":"Med. Princ. Pract."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.gendis.2023.02.027","article-title":"Clinical applications of the CRISPR\/Cas9 genome-editing system: delivery options and challenges in precision medicine","volume":"11","author":"Khoshandam","year":"2024","journal-title":"Genes. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","article-title":"Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects","volume":"20","author":"Kiaie","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ymeth.2021.04.007","article-title":"CRISPR-Cas systems for diagnosing infectious diseases","volume":"203","author":"Kostyusheva","year":"2022","journal-title":"Methods"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1021\/acs.molpharmaceut.1c00770","article-title":"Surface-engineered mucus penetrating nucleic acid delivery systems with cell penetrating peptides for the lungs","volume":"19","author":"Kumari","year":"2022","journal-title":"Mol. Pharm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.7774\/cevr.2025.14.e32","article-title":"Influenza C virus in humans and animals","volume":"14","author":"Lee","year":"2025","journal-title":"Clin. Exp. Vaccine Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/biomedicines10092179","article-title":"Lipid nanoparticles as delivery vehicles for inhaled therapeutics","volume":"10","author":"Leong","year":"2022","journal-title":"Biomedicines"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1039\/d4an01328j","article-title":"An amplification-free digital droplet assay for influenza A viral RNA based on CRISPR\/Cas13a","volume":"150","author":"Liu","year":"2025","journal-title":"Analyst"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.13345\/j.cjb.210739","article-title":"Application of nanoparticles in CRISPR\/Cas9-based gene therapy","volume":"38","author":"Ma","year":"2022","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1039\/d5lc00156k","article-title":"Preclinical assessment of pan-influenza A virus CRISPR RNA therapeutics in a human lung alveolus chip","volume":"25","author":"Man","year":"2025","journal-title":"Lab. Chip"},{"key":"B36","doi-asserted-by":"publisher","first-page":"114222","DOI":"10.1016\/j.ejpb.2024.114222","article-title":"Kinetics of RNA-LNP delivery and protein expression","volume":"197","author":"M\u00fcller","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e2020401118","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/pharmaceutics15020699","article-title":"Modulating inflammation-mediated diseases via natural phenolic compounds loaded in nanocarrier systems","volume":"15","author":"Rakotondrabe","year":"2023","journal-title":"Pharmaceutics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1038\/s41467-024-50080-y","article-title":"HLTF disrupts Cas9-DNA post-cleavage complexes to allow DNA break processing","volume":"15","author":"Reginato","year":"2024","journal-title":"Nat. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1248\/bpb.b25-00071","article-title":"Development of nanoparticle-based mucosal drug delivery systems for controlling pharmacokinetic behaviors","volume":"48","author":"Sato","year":"2025","journal-title":"Biol. and Pharm. Bull."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1700432","DOI":"10.1002\/biot.201700432","article-title":"Split Cas9, not hairs - advancing the therapeutic index of CRISPR technology","volume":"13","author":"Schmelas","year":"2018","journal-title":"Biotechnol. J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2024.2351657","article-title":"Programmable RNA targeting with CRISPR-Cas13","volume":"21","author":"Shi","year":"2024","journal-title":"RNA Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.13345\/j.cjb.200401","article-title":"CRISPR\/Cas9 technology in disease research and therapy: a review","volume":"37","author":"Shi","year":"2021","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"B44","doi-asserted-by":"publisher","first-page":"105381","DOI":"10.1016\/j.jddst.2024.105381","article-title":"Nano-based carriers for pulmonary drug delivery: a review on the available drug delivery applications and toxicity issues","volume":"92","author":"Siafaka","year":"2024","journal-title":"J. DRUG Deliv. Sci. Technol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/v14051036","article-title":"Comparing influenza virus biology for understanding influenza D virus","volume":"14","author":"Skelton","year":"2022","journal-title":"Viruses"},{"key":"B46","doi-asserted-by":"publisher","first-page":"106638","DOI":"10.1016\/j.micpath.2024.106638","article-title":"Infectious bronchitis virus (IBV) triggers autophagy to enhance viral replication by activating the VPS34 complex","volume":"190","author":"Song","year":"2024","journal-title":"Microb. Pathog."},{"key":"B47","doi-asserted-by":"publisher","first-page":"103302","DOI":"10.1016\/j.redox.2024.103302","article-title":"FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production","volume":"75","author":"Sun","year":"2024","journal-title":"Redox Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2026.114749","article-title":"A functional lyoprotectant platform enables storage-stable, mucus-penetrating siRNA delivery to the lung","volume":"393","author":"Sun","year":"2026","journal-title":"J. Control. Release"},{"key":"B49","doi-asserted-by":"publisher","first-page":"105421","DOI":"10.1016\/j.psj.2025.105421","article-title":"Genome-wide CRISPR\/Cas9 screen identifies host factors for Newcastle disease virus replication","volume":"104","author":"Tian","year":"2025","journal-title":"Poult. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jconrel.2024.08.019","article-title":"Enhanced delivery of CRISPR\/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy","volume":"374","author":"Wu","year":"2024","journal-title":"J. Control Release"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e2414651","DOI":"10.1002\/advs.202414651","article-title":"A susceptible cell-selective delivery (SCSD) of mRNA-Encoded Cas13d against influenza infection","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e2401632","DOI":"10.1002\/smtd.202401632","article-title":"Lipid nanoparticles for delivery of CRISPR gene editing components","volume":"10","author":"Wu","year":"2026","journal-title":"Small Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"932936","DOI":"10.3389\/fbioe.2022.932936","article-title":"Advantages of CRISPR-Cas9 combined organoid model in the study of congenital nervous system malformations","volume":"10","author":"Xiaoshuai","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"102350","DOI":"10.1016\/j.nano.2020.102350","article-title":"CRISPR: a new paradigm of theranostics","volume":"33","author":"Yadav","year":"2021","journal-title":"Nanomedicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41589-024-01593-6","article-title":"Structures, mechanisms and applications of RNA-centric CRISPR-Cas13","volume":"20","author":"Yang","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e00920","DOI":"10.1128\/msphere.00920-20","article-title":"Machine learning prediction and experimental validation of antigenic drift in H3 influenza A viruses in swine","volume":"6","author":"Zeller","year":"2021","journal-title":"mSphere"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s42003-025-08499-6","article-title":"Unique molecular signatures in rebound viruses from antiretroviral drug and CRISPR-treated HIV-1-infected humanized mice","volume":"8","author":"Zhang","year":"2025","journal-title":"Commun. Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e2300195","DOI":"10.1002\/advs.202300195","article-title":"Progress and perspective of CRISPR-Cas9 technology in translational medicine","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh)"}],"container-title":["Frontiers in Genome Editing"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2026.1844919\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:30:36Z","timestamp":1782365436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2026.1844919\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":58,"alternative-id":["10.3389\/fgeed.2026.1844919"],"URL":"https:\/\/doi.org\/10.3389\/fgeed.2026.1844919","relation":{},"ISSN":["2673-3439"],"issn-type":[{"value":"2673-3439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"article-number":"1844919"}}